TickerFactsScreenerDevelopers

Editas Medicine, Inc. (EDIT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $2.01M2014: $10.62M2015: $143.18M2016: $185.32M2017: $146.63M2018: $134.78M2019: $238.18M2020: $139.68M2021: $203.52M2022: $141.52M2023: $123.65M2024: $131.54M2025: $146.65M$146.65M
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$146.65M+11.5%
2024$131.54M+6.4%
2023$123.65M-12.6%
2022$141.52M-30.5%
2021$203.52M+45.7%
2020$139.68M-41.4%
2019$238.18M+76.7%
2018$134.78M-8.1%
2017$146.63M-20.9%
2016$185.32M+29.4%
2015$143.18M+1247.8%
2014$10.62M+428.0%
2013$2.01M—